Personalis, Inc., a Menlo Park, CA-based genomics-based clinical diagnostic laboratory, completed a $33m Series C financing round.
The round, which has raised $75m to date, was led by Lightspeed Venture Partners, with participation from Abingworth and Mohr Davidow Ventures.
The company intends to use the funds to scale its operations.
Led by John West, Chief Executive Officer, Personalis provides researchers and clinicians with advanced genome-scale sequencing and interpretation services for inherited genetic disease and cancer.
The company’s clinical laboratory is CLIA licensed and CAP accredited.